术前炎症标志物对胶质瘤的诊断价值:一项多中心队列研究
该多中心回顾性队列研究纳入2011年1月至2016年2月3家医院新诊断胶质瘤、听神经瘤、脑膜瘤或无病灶性癫痫患者及健康对照,比较术前NLR、dNLR、PLR、LMR、PNI及其配对组合对胶质瘤尤其GBM的诊断效能,发现NLR+LMR组合具有较高敏感度和特异度。
要点
- 胶质瘤患者术前NLR、dNLR高于健康对照及听神经瘤、脑膜瘤、无病灶性癫痫患者,LMR、PNI低于上述各组。
- NLR、dNLR、PLR与胶质瘤分级正相关,LMR、PNI与分级负相关。
- NLR+LMR组合诊断胶质瘤AUC为0.777,对GBM与其他疾病及低级别胶质瘤的鉴别具有较高准确度。
核心结论
- NLR+LMR组合是一种相对高敏感度和特异度的无创生物标志物,可用于胶质瘤诊断、胶质瘤与听神经瘤及脑膜瘤的鉴别诊断、GBM诊断以及GBM与低级别胶质瘤的鉴别诊断。
研究设计与样本
- 回顾性分析2011年1月至2016年2月3家医院新诊断胶质瘤、听神经瘤、脑膜瘤或无病灶性癫痫患者的病历资料。
- 共纳入750例胶质瘤患者(I级81例、II级208例、III级169例、IV级即GBM 292例)、44例听神经瘤、271例脑膜瘤、102例无病灶性癫痫患者及682例健康对照。
- 采用非参数检验比较各组NLR、dNLR、PLR、LMR、PNI值,分析其与肿瘤分级的相关性,并用受试者工作特征(ROC)曲线评估诊断效能。
主要发现
- 与健康对照及听神经瘤、脑膜瘤、无病灶性癫痫患者相比,胶质瘤患者术前NLR和dNLR更高、LMR和PNI更低;PLR在胶质瘤患者中高于健康对照和无病灶性癫痫患者。
- 亚组分析显示胶质瘤中NLR、dNLR、PLR与肿瘤分级正相关,LMR、PNI与肿瘤分级负相关。
- 诊断胶质瘤的AUC:NLR 0.722(0.697-0.747)、dNLR 0.696(0.670-0.722)、PLR 0.576(0.549-0.604)、LMR 0.760(0.738-0.783)、PNI 0.672(0.646-0.698)。
- NLR+LMR和dNLR+LMR组合诊断胶质瘤的AUC分别为0.777和0.778,诊断效能最佳。
- 与健康对照及其他疾病组相比,诊断GBM的AUC:NLR 0.860(95%CI 0.832-0.887)、dNLR 0.840(0.810-0.869)、PLR 0.678(0.641-0.715)、LMR 0.837(0.811-0.863)、PNI 0.740(0.706-0.773)。
临床怎么用
- 作者认为NLR+LMR组合可作为胶质瘤诊断、胶质瘤与听神经瘤及脑膜瘤鉴别、GBM诊断及GBM与低级别胶质瘤鉴别的无创生物标志物。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE Glioma is the most common form of brain tumor and has high lethality. The authors of this study aimed to elucidate the efficiency of preoperative inflammatory markers, including neutrophil/lymphocyte ratio (NLR), derived NLR (dNLR), platelet/lymphocyte ratio (PLR), lymphocyte/monocyte ratio (LMR), and prognostic nutritional index (PNI), and their paired combinations as tools for the preoperative diagnosis of glioma, with particular interest in its most aggressive form, glioblastoma (GBM). METHODS The medical records of patients newly diagnosed with glioma, acoustic neuroma, meningioma, or nonlesional epilepsy at 3 hospitals between January 2011 and February 2016 were collected and retrospectively analyzed. The values of NLR, dNLR, PLR, LMR, and PNI were compared among patients suffering from glioma, acoustic neuroma, meningioma, and nonlesional epilepsy and healthy controls by using nonparametric tests. Correlations between NLR, dNLR, PLR, LMR, PNI, and tumor grade were analyzed. Receiver operating characteristic (ROC) curve analysis was performed to evaluate the diagnostic significance of NLR, dNLR, PLR, LMR, PNI, and their paired combinations for glioma, particularly GBM. RESULTS A total of 750 patients with glioma (Grade I, 81 patients; Grade II, 208 patients; Grade III, 169 patients; Grade IV [GBM], 292 patients), 44 with acoustic neuroma, 271 with meningioma, 102 with nonlesional epilepsy, and 682 healthy controls were included in this study. Compared with healthy controls and patients with acoustic neuroma, meningioma, or nonlesional epilepsy, the patients with glioma had higher values of preoperative NLR and dNLR as well as lower values of LMR and PNI, whereas PLR was higher in glioma patients than in healthy controls and patients with nonlesional epilepsy. Subgroup analysis revealed a positive correlation between NLR, dNLR, PLR, and tumor grade but a negative correlation between LMR, PNI, and tumor grade in glioma. For glioma diagnosis, the area under the curve (AUC) obtained from the ROC curve was 0.722 (0.697-0.747) for NLR, 0.696 (0.670-0.722) for dNLR, 0.576 (0.549-0.604) for PLR, 0.760 (0.738-0.783) for LMR, and 0.672 (0.646-0.698) for PNI. The best diagnostic performance was obtained with the combination of NLR+LMR and dNLR+LMR, with AUCs of 0.777 and 0.778, respectively. Additionally, NLR (AUC 0.860, 95% CI 0.832-0.887), dNLR (0.840, 0.810-0.869), PLR (0.678, 0.641-0.715), LMR (0.837, 0.811-0.863), and PNI (0.740, 0.706-0.773) had significant predictive value for GBM compared with healthy controls and other disease groups. As compared with the Grade I-III glioma patients, the GBM patients had an AUC of 0.811 (95% CI 0.778-0.844) for NLR, 0.797 (0.763-0.832) for dNLR, 0.662 (0.622-0.702) for PLR, 0.743 (0.707-0.779) for LMR, and 0.661(0.622-0.701) for PNI. For the paired combinations, NLR+LMR demonstrated the highest accuracy. CONCLUSIONS The NLR+LMR combination was revealed as a noninvasive biomarker with relatively high sensitivity and specificity for glioma diagnosis, the differential diagnosis of glioma from acoustic neuroma and meningioma, GBM diagnosis, and the differential diagnosis of GBM from low-grade glioma.
引用
- Zheng SH, Huang JL, Chen M, et al. Diagnostic value of preoperative inflammatory markers in patients with glioma: a multicenter cohort study. J Neurosurg. 2017. PMID: 29099300. doi:10.3171/2017.3.JNS161648
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。